JS
Insider
Jeffrey Scott Sherman
Chief Financial OfficerJeffrey Scott Sherman (Chief Financial Officer) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in NeoGenomics, Inc. (NEO). Across 2 priced purchase filings, the average 21-session return was +21.1% from execution and +19.3% from disclosure (delay-adjusted; derived). The largest single filing was $150K of NEO (20,000 sh × $7.51, as filed), executed May 2 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+21.1%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+19.3%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$263K
shares × price, as filed
Last traded
Aug 6 2025
Filed Aug 6 2025
Median ADV $44.0M across their filed names
Open performance→Volume by month
Buys $263K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
NEORecent filings
NEOPURCHASE
NeoGenomics, Inc.
View filing →
$112K20,000 sh × $5.62
Exec Aug 6 2025
Filed Aug 6 2025 · 4:07 PM ET NEOPURCHASE NeoGenomics, Inc. View filing → $150K
20,000 sh × $7.51
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET